CNBC's Angelica Peebles reports the latest news surrounding Big Pharma.
Breakdown
- Eli Lilly to acquire Syntessa Pharmaceuticals for up to $7.8 billion 11s
- Syntessa develops orexin agonists for narcolepsy and neurological diseases 15s
- Biogen acquires Apellis Pharmaceuticals for about $5.6 billion 1m 18s
- Orexin agonist market could reach $15-20 billion annually 1m 3s
- Biotech sector sees increased M&A activity with more companies to watch 1m 50s